ADC Contract Manufacturing market Research Report by 2022, Forecast till 2035
In order to mitigate the challenges associated with ADC manufacturing, around 70-80% of the therapeutics developers prefer to outsource their operations to contract manufacturing organizations (CMOs), which claim to have the required expertise and experience to leverage their capabilities and yield cost savings opportunities.
The financial opportunity within the ADC contract market has been analyzed across the following segments:
Scale of Operation
Commercial
Clinical
Phase of Development
Phase III
Phase II
Phase I
Type of Component Manufacturing
Antibody manufacturing
HPAPI / Cytotoxic Payload and Linker Manufacturing
Conjugation
Fill / Finish
Target Indication
Solid Tumors
Hematological Malignancies
Others
Type of Payload Used
Maytansinoid
Auristatin
Camptothecin
PBD
Others
Type of Linker Used
SMCC
VC
Malemide
Peptide Linker
Others
Type of Antibody Origin
Humanized
Chimeric
Murine
Human
Others
Type of Antibody Isotype
IgG1
Others
Key Geographical Regions
North America
Europe
Asia-Pacific
Rest of the World
The ADC Contract Manufacturing Market (5th Edition), 2022-2035 report features the following companies, which we identified to be key players in this domain:
MabPlex
AbbVie Contract Manufacturing
Lonza
Catalent Pharma Solutions
Goodwin Biotechnology
MilliporeSigma
Piramal Pharma Solutions
Wuxi Biologics
Abzena
CARBOGEN AMCIS
Cerbios-Pharma
Formosa Laboratories
Creative Biolabs
Novasep
Sterling Pharma Solutions
Table of Contents
1. PREFACE
2. EXECUTIVE SUMMARY
3. INTRODUCTION
4. ADC CONTRACT MANUFACTURING SERVICE PROVIDERS: MARKET LANDSCAPE
5. COMPANY PROFILES
6. COMPANY COMPETITIVENESS ANALYSIS
7. ADC CONTRACT MANUFACTURING SERVICE PROVIDERS: RECENT EXPANSIONS
8. ADC CONTRACT MANUFACTURING SERVICE PROVIDERS: PARTNERSHIPS AND COLLABORATIONS
9. MAKE VERSUS BUY DECISION MAKING
10. VALUE CHAIN ANALYSIS
11. ADC MANUFACTURING: CAPACITY ANALYSIS
12. ADC THERAPEUTICS: MARKET OVERVIEW
13. NOVEL ADC CONJUGATION TECHNOLOGY PLATFORMS
14. CLINICAL TRIALS ANALYSIS
15. LIKELY PARTNER ANALYSIS
16. ADC THERAPEUTICS: DEMAND ANALYSIS
17. REGIONAL CAPABILITY ASSESSMENT ANALYSIS
18. ATTRACTIVENESS COMPETETIVENESS MATRIX
19. MARKET SIZING AND OPPORTUNITY ANALYSIS
20. SWOT ANALYSIS
21. CONCLUDING REMARKS
22. INTERVIEW TRANSCRIPTS
23. APPENDIX I: TABULATED DATA
24. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/view_documen
You may also be interested in the following titles:
Oral Solid Dosage Manufacturing Market
Lipid Nanoparticles in Drug Delivery
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#adccontractmanufacturingmarket #adccontractmanufacturingmarketsize #adcs #adcmanufacturing #antibodydrugconjugate